138 related articles for article (PubMed ID: 26059528)
1. Clinical investigation of TROP-2 as an independent biomarker and potential therapeutic target in colon cancer.
Zhao P; Yu HZ; Cai JH
Mol Med Rep; 2015 Sep; 12(3):4364-4369. PubMed ID: 26059528
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma.
Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H
Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000
[TBL] [Abstract][Full Text] [Related]
3. Different effects of ERβ and TROP2 expression in Chinese patients with early-stage colon cancer.
Fang YJ; Wang GQ; Lu ZH; Zhang L; Li JB; Wu XJ; Ding PR; Ou QJ; Zhang MF; Jiang W; Pan ZZ; Wan DS
Tumour Biol; 2012 Dec; 33(6):2227-35. PubMed ID: 23055188
[TBL] [Abstract][Full Text] [Related]
4. TROP2 overexpression promotes proliferation and invasion of lung adenocarcinoma cells.
Li Z; Jiang X; Zhang W
Biochem Biophys Res Commun; 2016 Jan; 470(1):197-204. PubMed ID: 26773504
[TBL] [Abstract][Full Text] [Related]
5. [Expression of TROP2 mRNA in left-sided and right-sided colon cancer and its clinical significance].
Xu KY; Gu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):285-9. PubMed ID: 19434540
[TBL] [Abstract][Full Text] [Related]
6. Association of tumor TROP2 expression with prognosis varies among lung cancer subtypes.
Inamura K; Yokouchi Y; Kobayashi M; Ninomiya H; Sakakibara R; Subat S; Nagano H; Nomura K; Okumura S; Shibutani T; Ishikawa Y
Oncotarget; 2017 Apr; 8(17):28725-28735. PubMed ID: 28404926
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of TROP2 expression in patients with gallbladder cancer.
Chen MB; Wu HF; Zhan Y; Fu XL; Wang AK; Wang LS; Lei HM
Tumour Biol; 2014 Nov; 35(11):11565-9. PubMed ID: 25135430
[TBL] [Abstract][Full Text] [Related]
8. Could trop-2 overexpression indicate tumor aggressiveness among prostatic adenocarcinomas?
Akarken İ; Dere Y
Ann Diagn Pathol; 2021 Feb; 50():151680. PubMed ID: 33341704
[TBL] [Abstract][Full Text] [Related]
9. Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer.
Fang YJ; Lu ZH; Wang GQ; Pan ZZ; Zhou ZW; Yun JP; Zhang MF; Wan DS
Int J Colorectal Dis; 2009 Aug; 24(8):875-84. PubMed ID: 19421758
[TBL] [Abstract][Full Text] [Related]
10. TROP2 expression as prognostic marker for gastric carcinoma.
Mühlmann G; Spizzo G; Gostner J; Zitt M; Maier H; Moser P; Gastl G; Zitt M; Müller HM; Margreiter R; Ofner D; Fong D
J Clin Pathol; 2009 Feb; 62(2):152-8. PubMed ID: 18930986
[TBL] [Abstract][Full Text] [Related]
11. TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity.
Fong D; Spizzo G; Gostner JM; Gastl G; Moser P; Krammel C; Gerhard S; Rasse M; Laimer K
Mod Pathol; 2008 Feb; 21(2):186-91. PubMed ID: 18084248
[TBL] [Abstract][Full Text] [Related]
12. TROP2 expression and its evolving role in tumor pathogenesis in systemic tumors.
Kapoor S
Tumour Biol; 2013 Jun; 34(3):1967-8. PubMed ID: 23150179
[No Abstract] [Full Text] [Related]
13. The Rise of the TROP2-Targeting Agents in NSCLC: New Options on the Horizon.
Ahmed Y; Berenguer-Pina JJ; Mahgoub T
Oncology; 2021; 99(10):673-680. PubMed ID: 34280931
[TBL] [Abstract][Full Text] [Related]
14. Expression of Trop2 cell surface glycoprotein in normal and tumor tissues: potential implications as a cancer therapeutic target.
Stepan LP; Trueblood ES; Hale K; Babcook J; Borges L; Sutherland CL
J Histochem Cytochem; 2011 Jul; 59(7):701-10. PubMed ID: 21551320
[TBL] [Abstract][Full Text] [Related]
15. The expression of metastasis-associated in colon cancer-1 and KAI1 in gastric adenocarcinoma and their clinical significance.
Lu G; Zhou L; Zhang X; Zhu B; Wu S; Song W; Gong X; Wang D; Tao Y
World J Surg Oncol; 2016 Oct; 14(1):276. PubMed ID: 27793161
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of EpCAM and Trop2 in pituitary adenomas.
Chen X; Pang B; Liang Y; Xu SC; Xin T; Fan HT; Yu YB; Pang Q
Int J Clin Exp Pathol; 2014; 7(11):7907-14. PubMed ID: 25550831
[TBL] [Abstract][Full Text] [Related]
17. High expression of TROP2 correlates with poor prognosis in pancreatic cancer.
Fong D; Moser P; Krammel C; Gostner JM; Margreiter R; Mitterer M; Gastl G; Spizzo G
Br J Cancer; 2008 Oct; 99(8):1290-5. PubMed ID: 18813308
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact of TROP2 in non-small lung cancers and its correlation with abnormal p53 nuclear accumulation.
Mito R; Matsubara E; Komohara Y; Shinchi Y; Sato K; Yoshii D; Ohnishi K; Fujiwara Y; Tomita Y; Ikeda K; Sakagami T; Suzuki M
Pathol Int; 2020 May; 70(5):287-294. PubMed ID: 32039532
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of trophoblastic cell surface antigen 2 expression and pathologic parameters in patients with ampullary adenocarcinoma.
Zhang Y; Wang H; Overman M; Katz MH; Wang H
Hum Pathol; 2023 Sep; 139():117-125. PubMed ID: 37516386
[TBL] [Abstract][Full Text] [Related]
20. Trop2 is overexpressed in gastric cancer and predicts poor prognosis.
Zhao W; Zhu H; Zhang S; Yong H; Wang W; Zhou Y; Wang B; Wen J; Qiu Z; Ding G; Feng Z; Zhu J
Oncotarget; 2016 Feb; 7(5):6136-45. PubMed ID: 26716416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
